Bevacimab – 100 mg/4 ml IV Infusion

14,568.89৳ 

Dosage : IV Infusion
Strength : 100 mg/4 ml
Generic : Bevacizumab
Pack Size : 1 Pack = NA
Manufacturer : Healthcare Pharmaceuticals Ltd.

+
  • Bevacimab - 100 mg/4 ml IV Infusion

    14,568.89৳ 

    Request a Call Back

    •  Size Guide

      Size Guide

    •  Delivery & Return

      Delivery

      Delivery Type

      Delivery Charge

      Delivery Time

      Free Delivery

      Free

      01 – 48 Hours

      Regular Delivery

      Tk. 25

      01 – 48 Hours

      Express Delivery

      Tk. 80

      01 – 03 Hours

      Store Pickup

      Free

      Currently, we deliver within 01 KM radius, Except as per the discussion

      Returns

      Return  FREE

      You can easily return your ordered medicine if :

      • Product Damaged
      • Expired
      • or Wrong Medicine

      found above issue please return to our delivery personnel during delivery time. After that we are unable to return your medicine.

    •  Ask a Question

      Bevacimab - 100 mg/4 ml IV Infusion

      14,568.89৳ 

      Ask a Question

        ... people are viewing this right now

        Share
      Guaranteed Safe CheckoutTrust
      Metastatic Colorectal Cancer (mCRC): The recommended doses are 5 mg/kg or 10 mg/kg every 2 weeks when used in combination with intravenous 5-FU-based chemotherapy.

      • Administer 5 mg/kg when used in combination with bolus-IFL.
      • Administer 10 mg/kg when used in combination with FOLFOX4.
      • Administer 5 mg/kg every 2 weeks or 7.5 mg/kg every 3 weeks when used in combination with a fluoropyrimidine-irinotecan or fluoropyrimidine-oxaliplatin based chemotherapy regimen in patients who have progressed on a first-line Bevacizumab-containing regimen.

      Non-Squamous Non-Small Cell Lung Cancer (NSCLC): The recommended dose is 15 mg/kg every 3 weeks in combination with carboplatin and paclitaxel.

      Glioblastoma: The recommended dose is 10 mg/kg every 2 weeks.

      Metastatic Renal Cell Carcinoma (mRCC): The recommended dose is 10 mg/kg every 2 weeks in combination with interferon alfa.

      Cervical Cancer: The recommended dose of Bevacizumab is 15 mg/kg every 3 weeks as an intravenous infusion administered in combination with one of the following chemotherapy regimens: paclitaxel and cisplatin, or paclitaxel and topotecan.

      Platinum-Resistant Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer: The recommended dose is 10mg/ kg every 2 weeks in combination with one of the following intravenous chemotherapy regimens: paclitaxel, pegylated liposomal doxorubicin, or topotecan (weekly); or 15 mg/kg every 3 weeks in combination with topotecan (every 3 weeks).

      Based on 0 reviews

      0.00 Overall
      0%
      0%
      0%
      0%
      0%
      Be the first to review “Bevacimab – 100 mg/4 ml IV Infusion”

      Your email address will not be published. Required fields are marked *

      Write a review

      Reviews

      There are no reviews yet.

      SKU: 201930 Category:  Tag: 
      My Cart
      Close Wishlist
      Close Recently Viewed
      Categories